HCAT vs. DCBO, SMWB, SIFY, SPT, KIND, HUYA, VTEX, SABR, BMBL, and CINT
Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Docebo (DCBO), Similarweb (SMWB), Sify Technologies (SIFY), Sprout Social (SPT), Nextdoor (KIND), HUYA (HUYA), VTEX (VTEX), Sabre (SABR), Bumble (BMBL), and CI&T (CINT). These companies are all part of the "computer software" industry.
Health Catalyst vs. Its Competitors
Docebo (NASDAQ:DCBO) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.
Docebo has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500.
Docebo currently has a consensus target price of $43.00, indicating a potential upside of 43.33%. Health Catalyst has a consensus target price of $4.73, indicating a potential upside of 63.57%. Given Health Catalyst's higher probable upside, analysts plainly believe Health Catalyst is more favorable than Docebo.
Docebo has higher earnings, but lower revenue than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks.
Docebo has a net margin of 9.29% compared to Health Catalyst's net margin of -31.67%. Docebo's return on equity of 60.39% beat Health Catalyst's return on equity.
53.2% of Docebo shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Docebo had 1 more articles in the media than Health Catalyst. MarketBeat recorded 4 mentions for Docebo and 3 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 1.69 beat Docebo's score of 1.62 indicating that Health Catalyst is being referred to more favorably in the news media.
Summary
Docebo beats Health Catalyst on 10 of the 16 factors compared between the two stocks.
Get Health Catalyst News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Health Catalyst Competitors List
Related Companies and Tools
This page (NASDAQ:HCAT) was last updated on 9/22/2025 by MarketBeat.com Staff
Free HCAT Stock Alerts